CERO THERAPEUTICS HOLDINGS, INC. Interest Expense
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Interest Expense of $14.43 thousand for the 2-month period ending 2024-03-31, per its 10-Q filed 2024-05-17.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-05-17
- CERO THERAPEUTICS HOLDINGS, INC. interest expense for the quarter ending 2023-03-31 was -$16.00.
| Period end | Interest Expense 1 month | Interest Expense 2 month | Interest Expense 3 month |
|---|---|---|---|
| 2024-03-31 | $14.43K 10-Q · filed 2024-05-17 | ||
| 2024-02-13 | -$4.80K 10-Q · filed 2024-05-17 | ||
| 2023-03-31 | -$16.00 10-Q · filed 2024-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |